4DMedical Limited (ASX:4DX)
1.755
-0.175 (-9.07%)
Oct 17, 2025, 4:10 PM AEST
4DMedical Revenue
In the fiscal year ending June 30, 2025, 4DMedical had annual revenue of 5.85 million AUD with 55.91% growth. 4DMedical had revenue of 2.96 million in the half year ending June 30, 2025, with 1,171.16% growth.
Revenue
5.85M
Revenue Growth
+55.91%
P/S Ratio
150.91
Revenue / Employee
47.20K
Employees
124
Market Cap
883.32M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 5.85M | 2.10M | 55.91% |
Jun 30, 2024 | 3.75M | 3.04M | 422.45% |
Jun 30, 2023 | 718.58K | -335.72K | -31.84% |
Jun 30, 2022 | 1.05M | 837.32K | 385.90% |
Jun 30, 2021 | 216.98K | -1.02M | -82.40% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Ramsay Health Care | 17.79B |
Sonic Healthcare | 9.65B |
Ansell | 3.06B |
Cochlear | 2.34B |
Regis Healthcare | 1.16B |
Telix Pharmaceuticals | 1.01B |
Neuren Pharmaceuticals | 218.86M |